Transparent Ultrathin Nanomembranes for Barrier Cell Models and Novel Co-Culture Systems

Information

  • Research Project
  • 10127134
  • ApplicationId
    10127134
  • Core Project Number
    R35GM119623
  • Full Project Number
    3R35GM119623-05S1
  • Serial Number
    119623
  • FOA Number
    PA-18-591
  • Sub Project Id
  • Project Start Date
    9/1/2016 - 7 years ago
  • Project End Date
    5/31/2021 - 2 years ago
  • Program Officer Name
    SMITH, WARD
  • Budget Start Date
    6/1/2020 - 3 years ago
  • Budget End Date
    5/31/2021 - 2 years ago
  • Fiscal Year
    2020
  • Support Year
    05
  • Suffix
    S1
  • Award Notice Date
    7/30/2020 - 3 years ago

Transparent Ultrathin Nanomembranes for Barrier Cell Models and Novel Co-Culture Systems

Abstract The overarching goals of this proposal are to; one, research and develop transparent ultrathin nanomembranes and two, utilize these membranes to advance biomedical in vitro model systems through work in the laboratory of the PI and an array of current and future collaborators. Nanomembrane development will include research towards fabricating ultrathin nanoporous silicon dioxide membranes, scaling up their active area, creating unique surface chemistries to promote cellular interaction and integration of sensor technologies. This proposal will enable collaborators to visualize endothelial barrier transmigration, produce better in vitro corneal models and visualize motile cilia in a patient derived primary lung model of cystic fibrosis. In addition, nanomembrane development through this proposal will enable and supply new collaborators with the tools to solve existing challenges and expand their respective fields. A common need is the ability to culture cells in a physiologically relevant model system that can be visualized in real-time. Transparent ultrathin porous membranes can accomplish this for almost any barrier model and co-culture system. SiO2 nanomembranes enable co-cultured cells to be brought within physiological separations distances (~100 nm), while providing glass-like optical transparency and nearly unhindered transport of signaling molecules. Success in developing new human in vitro systems promises to reduce the reliance on animal models, while simultaneously increasing physiological relevance and accelerating drug development. These tissue- and organ-on-a-chips also make feasible live imaging of complex cellular events that require sophisticated and well-orchestrated microenvironments.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R35
  • Administering IC
    GM
  • Application Type
    3
  • Direct Cost Amount
    51309
  • Indirect Cost Amount
    0
  • Total Cost
    51309
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NIGMS:51309\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ROCHESTER INSTITUTE OF TECHNOLOGY
  • Organization Department
    BIOMEDICAL ENGINEERING
  • Organization DUNS
    002223642
  • Organization City
    ROCHESTER
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    146235608
  • Organization District
    UNITED STATES